Dexcom Inc. Stock
€53.94
Your prediction
Dexcom Inc. Stock
Pros and Cons of Dexcom Inc. in the next few years
Pros
Cons
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 0.170% | -5.979% | -14.530% | -14.095% | -5.897% | -49.645% | -30.445% |
| Baxter International | 0.300% | -0.097% | -14.116% | -53.329% | -11.196% | -61.310% | -79.793% |
| Teleflex Inc. | -0.980% | 5.759% | -3.810% | -21.705% | -0.980% | -56.087% | -70.977% |
| Dentsply Sirona Inc. | -1.510% | -0.395% | -17.599% | -26.377% | 5.214% | -72.139% | -81.273% |
Comments
News
2 Growth Stocks to Hold for the Next Decade
Over the past year, Intuitive Surgical (NASDAQ: ISRG) and DexCom (NASDAQ: DXCM) have faced headwinds, and have lagged the stock market as a result. Shares of the former are down 13% over the
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
Many pharmaceutical companies are looking to develop and market the now highly popular GLP-1 drugs, which help treat diabetes, help patients lose weight, and reduce their risk of a range of
DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?
It's been a tough year for DexCom (NASDAQ: DXCM), whose stock price is down 25% since the start of 2025. It's a surprising performance, given that the overall stock market has been doing well; you


